Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Understand how Health Canada classifies medical devices, when MDL or MDEL requirements apply, and how MDSAP and ISO 13485 support compliance. This guide explains licensing, submission, post-market duties, and inspection readiness for manufacturers entering the Canadian market.
Learn how foreign manufacturers can navigate Russia’s regulatory system through Roszdravnadzor requirements, EAEU pathways, risk classification, testing, documentation, and inspection readiness. This guide explains key approval steps and preparation strategies for successful medical device market access.
Explore how Japan regulates medical devices through JMDN classification, PMDA review, MAH requirements, QMS Ordinance 169, and different approval routes. This guide helps foreign manufacturers prepare correctly, reduce delays, and plan a smoother market-entry strategy.
Explore how FDA medical device submissions work across 510(k), De Novo, PMA, and eSTAR pathways. Learn how classification, predicate strategy, evidence planning, substantial equivalence, and quality documentation can support smoother premarket review and stronger regulatory readiness.
Explore the EU regulatory pathway for medical devices, including classification, conformity assessment, CE marking, EUDAMED registration, UDI controls, and notified body review. Learn which records reviewers cross-check and how manufacturers can maintain EU MDR compliance after market entry.
Explore the CDSCO medical device registration pathway, including risk classification, Indian Authorized Agent requirements, Form MD-14 and Form MD-15, technical dossier preparation, common approval delays, and inspection-ready evidence under the Medical Devices Rules 2017.
Learn how FDA device registration and listing connects with classification, product codes, 510(k) pathways, FURLS records, annual renewal, and inspection readiness. The guide also explains common data gaps that can delay imports or threaten U.S. market access.
This guide explains how manufacturers manage device classification, FDA listing, EU MDR conformity assessment, CE marking, UDI, EUDAMED, technical documentation, and post-market controls to reduce registration delays, inspection findings, and global market-access risks throughout the product lifecycle.
The IVDR transition is reshaping the EU diagnostics industry. This post explores how QA teams can handle real challenges during implementation—especially for Class B and C IVDs—while staying compliant with UDI, PMS, and performance evaluation requirements.
Understanding how clinical trials for medical devices are designed, conducted, and evaluated is critical in a highly regulated market. Here’s a clear, current, and professional look into the world of medical device clinical trials in 2025.